by Lawrence Mouawad | May 28, 2020 | Uncategorised
Bern, Switzerland, 28th May 2020. “The psychological well-being of CML patients should be a consideration of healthcare professionals and addressed at all stages of the treatment-free remission journey” CML Advocates Network, the global network connecting 125 CML...
by Lawrence Mouawad | Apr 28, 2020 | Uncategorised
The CML Advocates Network is closely monitoring the current COVID-19 outbreak worldwide. We are happy to announce the launch of a new website section to better inform the CML patient advocacy community on what is happening around Chronic Myeloid Leukemia and COVID-19...
by Lawrence Mouawad | Apr 2, 2020 | Uncategorised
The novel Coronavirus and the COVID-19 Disease Information for Chronic Phase Chronic Myeloid Leukemia Patients State of the Art as of 08 March 2020 Dr Michael Deininger (USA), Dr François Guilhot (France), Dr Jeroen Janssen (Netherlands), Dr Tim Hughes (Australia), Dr...
by Lawrence Mouawad | Jan 31, 2020 | Uncategorised
Achieving therapy-free remission (TFR) continues to be amongst the most discussed topics in CML at the moment. At this year’s ASH congress, the first plenary oral session on CML was dedicated to the topic of TFR and there were many posters as well. Overall, there is...
by Lawrence Mouawad | Jan 31, 2020 | Uncategorised
Patients, borders, money, and mission: A global perspective of chronic myeloid leukemia – Summary of the CML educational session from ASH 2019 – Chairs: Hemant Malhotra, MD, FRCP; Mahatma Gandhi Medical College Hospital, Jaipur, India Speakers: The US...
by Lawrence Mouawad | Jan 18, 2020 | Uncategorised
This summary will cover a few of the important topics regarding CML that were presented at ASH 2019 including: New Drugs for CML Update on the French and German Interferon combination studies Age-adjusted treatment in CML- Elderly and Pregnancy report for young CML...